ES2157975T3 - Soluciones farmaceuticas con solubilidad mejorada. - Google Patents

Soluciones farmaceuticas con solubilidad mejorada.

Info

Publication number
ES2157975T3
ES2157975T3 ES94904489T ES94904489T ES2157975T3 ES 2157975 T3 ES2157975 T3 ES 2157975T3 ES 94904489 T ES94904489 T ES 94904489T ES 94904489 T ES94904489 T ES 94904489T ES 2157975 T3 ES2157975 T3 ES 2157975T3
Authority
ES
Spain
Prior art keywords
improved solubility
pharmaceutical solutions
solutions
pharmaceutical
encapsulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94904489T
Other languages
English (en)
Inventor
Frank S S Morton
Rickey S Shelley
Mahendra S Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RP Scherer Technologies LLC
Original Assignee
RP Scherer Technologies LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RP Scherer Technologies LLC filed Critical RP Scherer Technologies LLC
Application granted granted Critical
Publication of ES2157975T3 publication Critical patent/ES2157975T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Abstract

SE PRESENTAN SOLUCIONES FARMACEUTICAMENTE ACEPTABLES DE AGENTES FARMACEUTICOS ACIDICOS, BASICOS O ANFOTERICOS. ESTAS SOLUCIONES SON ADECUADAS PARA SU ENCAPSULACION EN CAPSULAS DE GELATINA PARA SU POSTERIOR ADMINISTRACION ORAL E INCLUYEN EL AGENTE FARMACEUTICO, UNA ESPECIE IONICA Y UN SISTEMA SOLVENTE.
ES94904489T 1992-12-18 1993-12-15 Soluciones farmaceuticas con solubilidad mejorada. Expired - Lifetime ES2157975T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/993,305 US5376688A (en) 1992-12-18 1992-12-18 Enhanced solubility pharmaceutical solutions

Publications (1)

Publication Number Publication Date
ES2157975T3 true ES2157975T3 (es) 2001-09-01

Family

ID=25539370

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94904489T Expired - Lifetime ES2157975T3 (es) 1992-12-18 1993-12-15 Soluciones farmaceuticas con solubilidad mejorada.

Country Status (8)

Country Link
US (1) US5376688A (es)
EP (1) EP0678019B1 (es)
JP (1) JP3739391B2 (es)
AU (1) AU692431B2 (es)
CA (1) CA2152062C (es)
DE (1) DE69330353T2 (es)
ES (1) ES2157975T3 (es)
WO (1) WO1994014423A1 (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3121080B2 (ja) * 1991-12-19 2000-12-25 アール・ピー・シーラー コーポレイション カプセル封入用溶液
DE69435104D1 (de) 1993-09-28 2008-07-31 Scherer Gmbh R P Herstellung von Weichgelatinekapseln
US6312704B1 (en) * 1993-09-30 2001-11-06 Gattefosse, S.A. Orally administrable composition capable of providing enhanced bioavailability when ingested
US5468502A (en) * 1994-12-20 1995-11-21 American Home Products Corporation Ibuprofen enhancing solvent system
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
IT1286778B1 (it) * 1996-11-20 1998-07-17 Alfa Wassermann Spa Capsule contenenti diclofenac o suoi sali in soluzione
WO1998038987A1 (en) * 1997-03-03 1998-09-11 Sanofi-Synthelabo Pharmaceutical formulations containing poorly soluble drug substances
SI0989851T1 (en) 1997-07-29 2003-04-30 Pharmacia & Upjohn Company Self-emulsifying formulation for acidic lipophilic compounds
GB2331458B (en) * 1997-11-21 2002-07-31 Gursharan Singh Moonga Solubilising systems for difficult pharmaceutical actives for preparing concentrated stable solutions for encapsulation into soft gelatine
US6761903B2 (en) 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6294192B1 (en) 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
US6383471B1 (en) * 1999-04-06 2002-05-07 Lipocine, Inc. Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
US6251426B1 (en) 1999-09-02 2001-06-26 Banner Pharmacaps, Inc. Ibuprofen-containing softgels
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
WO2001078724A1 (en) * 2000-04-18 2001-10-25 Pharmacia Corporation Rapid-onset formulation of a selective cyclooxigenase-2
PT1321140E (pt) * 2000-08-25 2005-06-30 Kowa Co Solucoes de ibuprofeno para o enchimento de capsulas e preparacoes de capsula
US6387400B1 (en) 2000-08-29 2002-05-14 R.P. Scherer Technologies, Inc. Process for preparing pharmaceutical compositions for use with soft gelatin formulations
WO2002069936A2 (en) * 2001-03-02 2002-09-12 Dr. Reddy's Laboratories Ltd. Pharmaceutical composition of ibuprofen
US20030034458A1 (en) * 2001-03-30 2003-02-20 Fuji Photo Film Co., Ltd. Radiation image storage panel
EP1269994A3 (en) * 2001-06-22 2003-02-12 Pfizer Products Inc. Pharmaceutical compositions comprising drug and concentration-enhancing polymers
US6828301B2 (en) * 2002-02-07 2004-12-07 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for hepatitis C viral protease inhibitors
EP1344523A1 (en) 2002-03-11 2003-09-17 Warner-Lambert Company Ibuprofen solution for hard gelatin capsules
CN1655770A (zh) 2002-04-25 2005-08-17 旗帜药物胶囊公司 可咀嚼的软胶囊
US20030232097A1 (en) * 2002-06-17 2003-12-18 Strides Inc. Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen
US20060241175A1 (en) * 2002-09-27 2006-10-26 Joseph Schwarz Vehicle for topical delivery of anti-inflammatory compounds
US7138394B2 (en) * 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
US20040146537A1 (en) * 2003-01-28 2004-07-29 Ramachandran Radhakrishnan Oily wax matrix suspension formulation comprising pharmacologically active agents
US20090318558A1 (en) * 2003-02-12 2009-12-24 Jae-Hwan Kim Solvent system of hardly soluble drug with improved dissolution rate
JP2006514119A (ja) * 2003-02-12 2006-04-27 アール アンド ピー コリア カンパニー リミテッド 溶解率が向上した難溶性薬剤の溶媒系
EP1684732A2 (en) * 2003-11-12 2006-08-02 Ranbaxy Laboratories Limited Ibuprofen-containing soft gelatin capsules
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
WO2005063219A2 (en) * 2003-12-23 2005-07-14 Ranbaxy Laboratories Limited Ibuprofen-containing soft gelatin capsules
US20050142185A1 (en) * 2003-12-29 2005-06-30 Beleno Alfredo B. Softgel formulations of bisphosphonates bone resorption inhibitors
US20050152968A1 (en) * 2004-01-09 2005-07-14 Brophy Kristine M. Microemulsions for pharmaceutical compositions
WO2005123133A1 (en) * 2004-06-18 2005-12-29 Ranbaxy Laboratories Limited A process for preparing ibuprofen soft gelatin capsules
WO2006034147A2 (en) * 2004-09-16 2006-03-30 Abraxis Bioscience, Inc. Compositions and methods for the preparation and administration of poorly water soluble drugs
US8231896B2 (en) 2004-11-08 2012-07-31 R.P. Scherer Technologies, Llc Non-gelatin soft capsule system
EP1926481A2 (en) * 2005-09-19 2008-06-04 Albermarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
US7582679B2 (en) * 2006-02-03 2009-09-01 Pharmaceutics International Incorporated Compositions containing solid ibuprofen concentrates and methods of making solid ibuprofen concentrates
EP2099431B1 (en) * 2006-11-28 2013-06-05 Laboratorios Liconsa, S.A. Stabilized solid pharmaceutical composition of candesartan cilexetil
WO2009069139A1 (en) * 2007-11-28 2009-06-04 Alkem Laboratories Ltd. Dosage form providing an ibuprofen-containing liquid fill
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
BRPI0916344A2 (pt) 2008-07-21 2020-07-21 Albemarle Corporation grânulos com alto teor de ibuprofeno de sódio, preparação e utilização para preparação de formas de dosagem sólidas não efervescentes
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
WO2019224832A1 (en) 2018-05-25 2019-11-28 Strides Shasun Limited Process for preparing pharmaceutical compositions resulting in reduction in overall fill volume for use with soft gelatin formulations
GB2595453B (en) 2020-05-21 2024-04-03 Reckitt Benckiser Health Ltd Novel Formulation
GB2595300B (en) 2020-05-21 2024-03-27 Reckitt Benckiser Health Ltd Novel Formulation
GB2595301A (en) 2020-05-21 2021-11-24 Reckitt Benckiser Health Ltd Novel formulation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
DE3307353C2 (de) * 1983-03-02 1985-01-31 R.P. Scherer GmbH, 6930 Eberbach Polyethylenglykolhaltige Weichgelatinekapsel und Verfahren zu ihrer Herstellung
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
DE3629386A1 (de) * 1986-08-29 1988-03-03 Scherer Gmbh R P Gelatinekapseln und verfahren zu ihrer herstellung
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US5141961A (en) * 1991-06-27 1992-08-25 Richrdson-Vicks Inc. Process for solubilizing difficulty soluble pharmaceutical actives
JPH0525037A (ja) * 1991-07-01 1993-02-02 Upjohn Co:The 経口投与酵素感受性腸溶製剤
US5200191A (en) * 1991-09-11 1993-04-06 Banner Gelatin Products Corp. Softgel manufacturing process

Also Published As

Publication number Publication date
AU692431B2 (en) 1998-06-11
WO1994014423A1 (en) 1994-07-07
JPH08507494A (ja) 1996-08-13
EP0678019B1 (en) 2001-06-13
EP0678019A1 (en) 1995-10-25
DE69330353T2 (de) 2002-05-02
JP3739391B2 (ja) 2006-01-25
AU5851894A (en) 1994-07-19
DE69330353D1 (de) 2001-07-19
CA2152062C (en) 1999-01-05
CA2152062A1 (en) 1994-07-07
US5376688A (en) 1994-12-27

Similar Documents

Publication Publication Date Title
ES2157975T3 (es) Soluciones farmaceuticas con solubilidad mejorada.
DE59802670D1 (de) Osmotisches arzneimittelfreisetzungssystem
CA2109623A1 (en) Process for solubilizing difficultly soluble pharmaceutical actives
ES2126536B1 (es) "preparado farmaceutico para administracion intranasal y procedimientopara su produccion".
CY1107675T1 (el) Φαρμακευτικα αλατα τραμαδολης
FI891921A (fi) Menetelmä oraalisen antosysteemin valmistamiseksi
DK146784D0 (da) Farmaceutisk doseringsenhedsform
ATE448782T1 (de) Pharmazeutische glutathionpräparate und methoden zu dern verabreichung
EE03805B1 (et) Peroraalselt manustatava farmatseutilise kompositsiooni kasutamine meeste erektiilse talitlushäire raviks ettenähtud ravimi valmistamiseks
NO177177C (no) Fremgangsmåte for fremstilling av en flytende doseringsform for oral administrasjon av en farmasöytisk substans
FI962948A (fi) Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuottamiseksi
ES2194989T3 (es) Composicion adminstrada por via oral, que comprende una toxina de zonula occludens y un agente que tiene una actividad biologica, y su utilizacion.
ATE232100T1 (de) Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
FR2612187B1 (fr) Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
SE8100276L (sv) Farmaceutiskt aktiv komposition omfattande ketoner och heterocykliska foreningar
NO20024737D0 (no) Farmasöytiske preparater og fremstilling derav
SE8701479L (sv) Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
FI913036A0 (fi) Terapeutiskt aktiv substituerad benzimidazol och foerfarande foer dess framstaellning.
AR025060A1 (es) Formulaciones farmaceuticas en capsulas de hidroxipropilmetilcelulosa
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
CO4970832A1 (es) Nuevas formulaciones y procesos para su fabricacion
MY100780A (en) Azumolene dosage form.
NO20004816L (no) Ny farmasøytisk formulering
ATE300293T1 (de) Pharmazeutische zusammensetzungen, die schwerlösliche arzneistoffe enthalten
ATE301453T1 (de) Injizierbare arzneiformulierungen von partricin derivaten

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 678019

Country of ref document: ES